Evidence map›Paper›PMID 39373785›Full record

ReviewVeterinary research communications2024

Bacterial diseases in Siniperca chuatsi: status and therapeutic strategies.

Zi Ying Zeng, Zhi Li Ding, Ai Ni Zhou, Chen Bin Zhu, Shun Yang, Hui Fei

Abstract readReview
PubMed Publisher
In one paragraph

Review in Veterinary research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. A teleost-specific oxygen-immunity axis where FIH activates NF-κB via competitive IκBα binding.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Zi Ying ZengCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Zhi Li DingCollege of Life Science, Huzhou University, Huzhou, 313000, China.
Ai Ni ZhouCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Chen Bin ZhuCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Shun YangCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China.
Hui FeiCollege of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, 310018, China. feihui@zstu.edu.cn.

Funding

Zhejiang Province Leading Geese Plan 2024C02012
6 · The paper itself

Abstract

Mandarin fish (Siniperca chuatsi) is a prominent freshwater species with significant economic value in China, while disease poses a major hindrance to the advancement of mandarin fish aquaculture. To date, the understanding of the prevention and management of bacterial disease in mandarin fish remains incomplete. Therefore, there is a need for more comprehensive insights into the preventive and curative strategies to address these bacterial infections. In this review, we summarize the information pertaining to the predominant bacterial pathogens such as Aeromonas spp., Flavobacterium columnare, Edwardsiella tarda, Streptococcus uberis and Vibrio cholerae in the mandarin fish aquaculture, and point out the current strategies for diagnosis and combating these bacterial pathogens, as well as deliberate on the prospective alternative treatments such as vaccines, herbal remedies, and phage therapy for the prevention and control of these bacterial diseases. Furthermore, we also highlights the importance to implement an integrated bacterial disease management (IBDM) approach for the prevention and control of these pathogenic bacteria in aquaculture.

Indexed as

Bacterial InfectionsFish DiseasesAnimalsAquaculturePerciformesBacterial infectionIntegrated bacterial disease managementSiniperca chuatsiTherapeutic approaches

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.